MetLife Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-71,835
| Closed | -$1.19M | – | 2732 |
|
|
2025
Q1 | $1.19M | Sell |
71,835
-1,213
| -2% | -$20.1K | 0.01% | 1274 |
|
|
2024
Q4 | $1.34M | Buy |
73,048
+2,669
| +4% | +$49K | 0.01% | 1266 |
|
|
2024
Q3 | $1.08M | Hold |
70,379
| – | – | 0.01% | 1348 |
|
|
2024
Q2 | $1.14M | Buy |
70,379
+6,624
| +10% | +$108K | 0.01% | 1274 |
|
|
2024
Q1 | $1.18M | Hold |
63,755
| – | – | 0.01% | 1213 |
|
|
2023
Q4 | $2M | Hold |
63,755
| – | – | 0.01% | 944 |
|
|
2023
Q3 | $1.33M | Hold |
63,755
| – | – | 0.01% | 1090 |
|
|
2023
Q2 | $1.53M | Hold |
63,755
| – | – | 0.01% | 1048 |
|
|
2023
Q1 | $1.2M | Sell |
63,755
-2,596
| -4% | -$48.9K | 0.01% | 1135 |
|
|
2022
Q4 | $1.06M | Hold |
66,351
| – | – | 0.01% | 1189 |
|
|
2022
Q3 | $1.09M | Hold |
66,351
| – | – | 0.01% | 1141 |
|
|
2022
Q2 | $935K | Hold |
66,351
| – | – | 0.01% | 1242 |
|
|
2022
Q1 | $1.61M | Buy |
66,351
+23,265
| +54% | +$563K | 0.01% | 1082 |
|
|
2021
Q4 | $1.01M | Hold |
43,086
| – | – | 0.01% | 1118 |
|
|
2021
Q3 | $716K | Hold |
43,086
| – | – | 0.01% | 1315 |
|
|
2021
Q2 | $1.05M | Buy |
+43,086
| New | +$1.05M | 0.01% | 1136 |
|
|
2020
Q2 | – | Sell |
-48,173
| Closed | -$2.04M | – | 2296 |
|
|
2020
Q1 | $2.04M | Hold |
48,173
| – | – | 0.03% | 601 |
|
|
2019
Q4 | $2.06M | Buy |
48,173
+2,065
| +4% | +$88.3K | 0.02% | 799 |
|
|
2019
Q3 | $1.66M | Sell |
46,108
-3,563
| -7% | -$128K | 0.02% | 856 |
|
|
2019
Q2 | $1.33M | Hold |
49,671
| – | – | 0.01% | 984 |
|
|
2019
Q1 | $1.33M | Buy |
49,671
+3,852
| +8% | +$103K | 0.01% | 964 |
|
|
2018
Q4 | $741K | Hold |
45,819
| – | – | 0.01% | 1147 |
|
|
2018
Q3 | $951K | Hold |
45,819
| – | – | 0.01% | 1151 |
|
|
2018
Q2 | $700K | Buy |
+45,819
| New | +$700K | 0.01% | 1202 |
|